Latest Advances for theSleeping BeautyTransposon System: 23 Years of Insomnia but Prettier than Ever Refinement and Recent Innovations of theSleeping BeautyTransposon System Enabling Novel, Nonviral Genetic Engineering Applications

被引:36
作者
Amberger, Maximilian [1 ]
Ivics, Zoltan [1 ]
机构
[1] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany
基金
欧盟地平线“2020”;
关键词
clinical trial; gene therapy; genome engineering; nonviral; Sleeping Beautytransposon; transgenesis; transposition; SLEEPING-BEAUTY-TRANSPOSON; PLURIPOTENT STEM-CELLS; SEVERE COMBINED IMMUNODEFICIENCY; INTRAVITREAL BEVACIZUMAB; PHENOTYPIC CORRECTION; SITE SELECTION; HUMAN GENOME; T-CELLS; TRANSGENE EXPRESSION; PIGGYBAC TRANSPOSON;
D O I
10.1002/bies.202000136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TheSleeping Beautytransposon system is a nonviral DNA transfer tool capable of efficiently mediating transposition-based, stable integration of DNA sequences of choice into eukaryotic genomes. Continuous refinements of the system, including the emergence of hyperactive transposase mutants and novel approaches in vectorology, greatly improve upon transposition efficiency rivaling viral-vector-based methods for stable gene insertion. Current developments, such as reversible transgenesis and proof-of-concept RNA-guided transposition, further expand on possible applications in the future. In addition, innate advantages such as lack of preferential integration into genes reduce insertional mutagenesis-related safety concerns while comparably low manufacturing costs enable widespread implementation. Accordingly, the system is recognized as a powerful and versatile tool for genetic engineering and is playing a central role in an ever-expanding number of gene and cell therapy clinical trials with the potential to become a key technology to meet the growing demand for advanced therapy medicinal products.
引用
收藏
页数:14
相关论文
共 155 条
  • [1] Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections
    Adelman, Ron A.
    Zheng, Qi
    Mayer, Hylton R.
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (01) : 105 - 110
  • [2] T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
    Ali, Syed Abbas
    Shi, Victoria
    Maric, Irina
    Wang, Michael
    Stroncek, David F.
    Rose, Jeremy J.
    Brudno, Jennifer N.
    Stetler-Stevenson, Maryalice
    Feldman, Steven A.
    Hansen, Brenna G.
    Fellowes, Vicki S.
    Hakim, Frances T.
    Gress, Ronald E.
    Kochenderfer, James N.
    [J]. BLOOD, 2016, 128 (13) : 1688 - 1700
  • [3] [Anonymous], J HEMATOL ONCOL
  • [4] Protonged expression of a tysosomat enzyme in mouse tiver after Sleeping Beauty transposon-mediated gene detivery:: imptications for non-virat gene therapy of mucopotysaccharidoses
    Aronovich, Elena L.
    Bell, Jason B.
    Belur, Lalitha R.
    Gunther, Roland
    Koniar, Brenda
    Erickson, David C. C.
    Schachem, Patricia A.
    Matise, Ilze
    McIvor, R. Scott
    Whitley, Chester B.
    Hackett, Perry B.
    [J]. JOURNAL OF GENE MEDICINE, 2007, 9 (05) : 403 - 415
  • [5] Systemic Correction of Storage Disease in MPS I NOD/SCID Mice Using the Sleeping Beauty Transposon System
    Aronovich, Elena L.
    Bell, Jason B.
    Khan, Shaukat A.
    Belur, Lalitha R.
    Gunther, Roland
    Koniar, Brenda
    Schachern, Patricia A.
    Parker, Josh B.
    Carlson, Cathy S.
    Whitley, Chester B.
    McIvor, R. Scott
    Gupta, Pankaj
    Hackett, Perry B.
    [J]. MOLECULAR THERAPY, 2009, 17 (07) : 1136 - 1144
  • [6] Small-scale GMP production of plasmid DNA using a simplified and fully disposable production method
    Bakker, Noor A. M.
    de Boer, Renate
    Marie, Corinne
    Scherman, Daniel
    Haanen, John B. A. G.
    Beijnen, Jos H.
    Nuijen, Bastiaan
    van den Berg, Joost H.
    [J]. JOURNAL OF BIOTECHNOLOGY, 2019, 306
  • [7] Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells for treatment of pancreatic cancer
    Batchu, Ramesh B.
    Gruzdyn, Oksana V.
    Tavva, Pavan S.
    Kolli, Bala K.
    Dachealli, Rajesh
    Weaver, Donald W.
    Gruber, Scott A.
    [J]. SURGERY, 2019, 166 (04) : 503 - 508
  • [8] Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors
    Beckmann, Pauline J.
    Larson, Jon D.
    Larsson, Alex T.
    Ostergaard, Jason P.
    Wagner, Sandra
    Rahrmann, Eric P.
    Shamsan, Ghaidan A.
    Otto, George M.
    Williams, Rory L.
    Wang, Jun
    Lee, Catherine
    Tschida, Barbara R.
    Das, Paramita
    Dubuc, Adrian M.
    Moriarity, Branden S.
    Picard, Daniel
    Wu, Xiaochong
    Rodriguez, Fausto J.
    Rosemarie, Quincy
    Krebs, Ryan D.
    Molan, Amy M.
    Demer, Addison M.
    Frees, Michelle M.
    Rizzardi, Anthony E.
    Schmechel, Stephen C.
    Eberhart, Charles G.
    Jenkins, Robert B.
    Wechsler-Reya, Robert J.
    Odde, David J.
    Huang, Annie
    Taylor, Michael D.
    Sarver, Aaron L.
    Largaespada, David A.
    [J]. CANCER RESEARCH, 2019, 79 (05) : 905 - 917
  • [9] Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease
    Belcher, John D.
    Vineyard, Julie V.
    Bruzzone, Carol M.
    Chen, Chunsheng
    Beckman, Joan D.
    Nguyen, Julia
    Steer, Clifford J.
    Vercellotti, Gregory M.
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (07): : 665 - 675
  • [10] Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System
    Belur, Lalitha R.
    Podetz-Pedersen, Kelly M.
    Sorenson, Brent S.
    Hsu, Alice H.
    Parker, Josh B.
    Carlson, Cathy S.
    Saltzman, Daniel A.
    Ramakrishnan, S.
    McIvor, R. Scott
    [J]. MOLECULAR CANCER, 2011, 10